Also, the Euro Heart Survey on Diabetes and the Heart investigated the impact of different glucose-lowering modalities on cardiovascular events including death, myocardial infarction and stroke, and found that insulin treatment may associated with a more serious prognosis in DM patients with coronary artery disease (9). The gene discussed is INS; the disease is myocardial infarction.